The Genentech 2001 Annual Report

Board of Directors | Officers | Staff Scientists | Distinguished Engineers

Board of Directors

Arthur D. Levinson, Ph.D.
Chairman and Chief Executive Officer
Genentech, Inc.

Herbert W. Boyer, Ph.D.
Co-founder of Genentech, Inc. and
Professor Emeritus of
Biochemistry and Biophysics
University of California, San Francisco

Franz B. Humer, Ph.D.
Chairman and Chief Executive Officer
The Roche Group, a research-based
healthcare company

Jonathan K. C. Knowles, Ph.D.
President of Global Research
The Roche Group, a research-based
healthcare company

Sir Mark Richmond, Ph.D.
Senior Research Fellow
School of Public Policy
University College, London

Charles A. Sanders, M.D.
Former Chairman and
Chief Executive Officer
Glaxo, Inc., a research-based
healthcare company

Officers

Arthur D. Levinson, Ph.D.*
Chairman and Chief Executive Officer

Susan D. Desmond-Hellmann, M.D., M.P.H.*
Executive Vice President
Development and
Product Operations and
Chief Medical Officer

Louis J. Lavigne, Jr.*
Executive Vice President and
Chief Financial Officer

Myrtle S. Potter*
Executive Vice President
Commercial Operations and
Chief Operating Officer

Stephen G. Juelsgaard, D.V.M., J.D.*
Senior Vice President,
General Counsel and Secretary

Richard H. Scheller, Ph.D.*
Senior Vice President
Research

David A. Ebersman
Senior Vice President
Product Operations

Robert L. Garnick, Ph.D.
Senior Vice President
Regulatory, Quality and Compliance

Paula M. Jardieu, Ph.D.
Senior Vice President
Development Sciences

Mark J. Ahn
Vice President
Hematology Marketing and Sales

W. Robert Arathoon, Ph.D.
Vice President
Corporate Manufacturing Operations

J. Joseph Barta
Vice President
Compliance

Ronald C. Branning
Vice President
Global Quality

Stephen G. Dilly, M.D., Ph.D.
Vice President
Medical Affairs

Claudia Estrin
Vice President
Decision Support and
Commercial Innovation

Roy C. Hardiman, J.D.
Vice President
Corporate Law and
Assistant Secretary

Francis A. Jackson
Vice President
Vacaville Product Operations

Sean A. Johnston, Ph.D.
Vice President
Intellectual Property and
Assistant Secretary

R. Guy Kraines
Vice President
Corporate Information Technology

Joseph S. McCracken, D.V.M.
Vice President
Business and Commercial Development

Walter K. Moore
Vice President
Government Affairs

Genesio Murano, Ph.D.
Vice President
Regulatory Affairs

David Nagler
Vice President
Human Resources

Diane L. Parks
Vice President
Cardiovascular and Specialty Therapeutics Marketing and Sales

Andrew Scherer
Vice President
Engineering, Facilities and
Genentech Espana

Bernice R. Welles, M.D.
Vice President
Product Development

John M. Whiting
Vice President,
Controller and
Chief Accounting Officer

Thomas T. Thomas, II
Treasurer

*member of executive committee

Staff Scientists

Avi J. Ashkenazi, Ph.D.
Research

Thomas A. Bewley, Ph.D.
Process Sciences

Stuart Bunting, Ph.D.
Research

Abraham De Vos, Ph.D.
Research

Vishva Dixit, Ph.D.
Research

Napoleone Ferrara, M.D.
Research

David Giltinan, Ph.D.
Medical Affairs

Tim Gregory, Ph.D.
Process Sciences

Andrew J.S. Jones, D. Phil.
Analytical Sciences

Timothy A. Stewart, Ph.D.
Research

William I. Wood, Ph.D.
Research

Distinguished Engineers

Chung Hsu, Ph.D., P.E.
Process Sciences

Robert van Reis
Process Sciences

Activase, Herceptin, Nutropin, Nutropin AQ, Protropin and Pulmozyme are registered trademarks, and Avastin, Cathflo Activase, Nutropin AQ Pen, Nutropin Depot, TNKase, Xanelim and Xolair are trademarks of Genentech, Inc. Rituxan is a registered trademark of IDEC Pharmaceuticals Corporation.